Skip to main content

Day: February 27, 2024

Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Q4 net product revenues for ZORYVE® (roflumilast) cream 0.3% were $13.5 million, a 357% increase compared to the fourth quarter of 2022 and a 67% increase compared to the third quarter of 2023; driven by sequential improvement in gross-to-net (GTN) in the mid 60 percent range, as well as sustained demand growth Received U.S. Food and Drug Administration (FDA) approval for ZORYVE® (roflumilast) topical foam, 0.3%, for the treatment of seborrheic dermatitis in adults and children down to age 9 in December 2023 and launched ZORYVE foam for seborrheic dermatitis in United States in late January 2024 July 7, 2024 PDUFA action date for roflumilast cream, 0.15%, for the treatment of atopic dermatitis in adults and children down to age 6 Strong financial position supports investment in plaque psoriasis and seborrheic dermatitis launches and continued...

Continue reading

IDEX Biometrics ASA – Invitation to presentation of fourth quarter and preliminary results for 2023

Oslo, Norway – 27 February 2024 – IDEX Biometrics will publish its interim report for the fourth quarter and preliminary results for 2023 on Thursday 29 February at 08:00 CET. The interim report will also be available on the company’s website: www.idexbiometrics.com. Webcast:There will be a webcast on Thursday 29 February 2024 at 09:00 CET.  The presentation will be held by Vince Graziani, Chief Executive Officer, and Catharina Ekløf, Chief Commercial Officer. The presentation file will be available at www.idexbiometirics.com, and the webcast presentation can be viewed using the following link: https://idexbiometrics.videosync.fi/q4-2023/ For further information contact:Marianne Bøe, Head of Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global...

Continue reading

Huhtamaki’s 2023 Annual Report published

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 27.2.2024 AT 12:00 EET Huhtamaki’s 2023 Annual Report published The Huhtamaki Annual Report 2023 has been published on the company’s website at www.huhtamaki.com/investors. It is comprised of four sections, with a Company overview, financials, governance (Corporate Governance Statement and Remuneration Report) and sustainability. The report is available in Finnish and English apart from the Sustainability Report, which is available only in English. The financial statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. The audit firm KPMG Oy Ab has provided an independent auditor’s reasonable assurance report on Huhtamaki’s ESEF Financial Statements in accordance with ISAE 3000 (Revised). The Annual Report is attached to this release...

Continue reading

Response to media reports about data theft

Over the past days Danish media have reported stories about a theft of source code involving Netcompany Denmark.  We can confirm one single incident involving a simple theft of Netcompany Denmark source code and user manuals.  We can refute that the incident is a ransomware attack.  The data theft has not affected Netcompany or our customer’s operations and services.  We know how the theft has occurred, the extent of the theft, and that the theft resides around source code and user manuals for Netcompany tools.  Since the simple theft was discovered, we have worked in close collaboration with authorities and have implemented additional mitigating actions to ensure a continued high level of security in our production systems landscape.  We have taken necessary precautions that ensure the stolen files cannot be used to gain unauthorized...

Continue reading

Digital Locations CEO Rich Berliner Discussed the Use of Technology for Monitoring and Fighting Wildfires with Research Scientist

Professor Dale Hamilton described his research focused on post-fire effects analysis and the transition from using drones to satellite imagery for broader coverage SANTA BARBARA, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) — Digital Locations, Inc. (OTCMKTS:DLOC), the developer of Satenna™, a breakthrough technology that will deliver high-speed Internet from satellites directly to smartphones all over the world, today announced that in a recent podcast, its CEO, Rich Berliner, spoke with Dale Hamilton, a professor at Northwest Nazarene University (NNU), about the potential of real-time data transmission and the integration of AI to enhance firefighting efforts. During the discussion, Dr. Hamilton expressed the importance of collaboration and innovation in leveraging technology to improve emergency response and potentially save lives....

Continue reading

Micron Collaborates with Samsung on Galaxy S24 Series to Unlock the Era of Mobile AI Experiences

Samsung’s flagship Galaxy S24 Ultra, S24+ and S24 incorporate Micron’s high-performance, power-efficient LPDDR5X and UFS 4.0 BARCELONA, Spain, Feb. 27, 2024 (GLOBE NEWSWIRE) — Mobile World Congress – Micron Technology, Inc. (Nasdaq: MU) announced today that Samsung has incorporated Micron’s low-power double data rate 5X (LPDDR5X) memory and Universal Flash Storage (UFS) 4.0 mobile flash storage into select devices in the Samsung Galaxy S24 series, which introduces powerful artificial intelligence (AI) to mobile users around the world. The Galaxy S24 series is underpinned by Samsung’s suite of generative AI tools, Galaxy AI, which helps amplify experiences from enabling barrier-free communication to maximizing creative freedom. As these data- and energy-intensive features push the limits of smartphones’ hardware capabilities, Micron’s...

Continue reading

WELL Health Founder & CEO Hamed Shahbazi Appointed Chairman of the Board of HEALWELL AI

Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care. Mr. Shahbazi’s appointment is strategically important for shareholders of both WELL and HEALWELL given the shared objective between the companies to create the most advanced and easy to use AI inspired tools that can equip care providers with various ‘Co-Pilots’ that can help them improve diagnosis of rare and chronic diseases, improve efficiency of their practice, and improve patient health outcomes. WELL is currently the largest shareholder of HEALWELL with ownership of 20.7% of the company’s issued and outstanding voting securities. WELL also has an option to acquire approximately 30 million multi-voting shares that would give WELL a controlling position in HEALWELL, as defined...

Continue reading

UAB “Atsinaujinančios energetikos investicijos“ publishes interim financial statements for the 12-month period of 2023

UAB “Atsinaujinančios energetikos investicijos” (the Company) publishes its unaudited interim condensed consolidated and separate financial statements for the 12-month period of 2023. Financial results The Company’s objective is to earn a return for the Company’s investors from investments in facilities of the renewable energy infrastructure and related assets. The main financial indicators for the period were:As at 31 December 2023, the Company’s total assets were EUR 186,793 thousand, total equity was EUR 115,300 thousand, and total liabilities were EUR 71,493 thousand. As at 31 December 2023, the Company’s investment assets at fair value through profit or loss were EUR 180,060 thousand, which compared to 31 December 2022, grew by EUR 35,152 thousand or 24.26%.For the period January – December 2023, the Company reported a...

Continue reading

LIFT intersects 22 m at 1.05% Li2O at its Fi Southwest pegmatite, Yellowknife Lithium Project, NWT

Figure 1Location of LIFT’s Yellowknife Lithium Project. Drilling has been thus far focused on the Near Field Group of pegmatites which are located to the east of the city of Yellowknife along a government-maintained paved highway, as well as the Echo target in the Further Afield Group.Figure 2Plan view showing the surface expression of the Fi Southwest pegmatite with diamond drill holes reported in this press release.Figure 3Cross-section illustrating YLP-0199 with results as shown in the Fi Southwest pegmatite dyke with a 22 m interval of 1.05% Li2O.Figure 4Plan view showing the surface expression of the Nite pegmatite with diamond drill holes reported in this press release.Figure 5Cross-section of YLP-0195 which intersected the Nite pegmatite dyke with a 15 m interval of 1.00% Li2O.Figure...

Continue reading

Inside information: SATO Corporation announces tender offer regarding outstanding EUR 350,000,000 notes due 24 February 2028

SATO Corporation, Stock Exchange Release 27 February 2024 at 9:55am SATO Corporation has today announced an invitation to holders of its outstanding EUR 350,000,000 1.375 per cent notes due 24 February 2028 (ISIN: XS2233121792) to tender such notes for cash up to an aggregate principal amount of EUR 50 million. The Tender Offer for the notes will be priced via an unmodified Dutch auction procedure with a minimum purchase price of 87,500 per cent. Expiration of the Tender Offer will be 15.00 CET on 5 March 2024 and settlement is expected to be on 8 March 2024. Details of the Tender Offer, the pricing mechanism and the timeline are available in the launch announcement via Euronext Dublin and the tender offer memorandum is available via the tender agent https://deals.is.kroll.com/SATO.   For more information, please contact: Markku Honkasalo,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.